Welwaze’s mission is to prevent breast cancer deaths. We are a purpose-driven health tech company that sits at the intersection of medical devices, artificial intelligence, and the healthcare industry. We strive to deliver innovative, viable, and scalable medical technologies.
Our unique ecosystem includes Celbrea TMDTM, an FDA-cleared medical device that supports early detection of breast abnormalities and a comprehensive companion app, that will have the potential to disrupt conventional breast-health programs and protocols. Celbrea TMDTM aims to deliver a safe, effective, non-invasive, and easy-to-use technology to support routine physical examination including palpation, mammography, and other established procedures for the detection of breast disease, including breast cancer.
Celbrea TMDTM is a functional test that measures absolute temperatures on the surface of the breasts and helps to determine if there is a significant difference between mirror segments of the right and left breast. Clinical studies have shown that a temperature difference of 2oF or more may be an indication of a potential underlying breast pathology.
The product incorporates more than 1,000 sensors in a biocompatible, multilayer pad specially designed to visually display color changes in accordance to surface temperatures in a woman’s breasts in just 15 minutes. Celbrea TMDTM has been extensively studied and validated via clinical trials in over 5,000 patients at established clinical research centers across the U.S., Europe, and South America. The Celbrea mobile app that is in development will use computer-vision to capture high-quality images that feed into a machine-learning algorithm to provide instant analysis and reporting capabilities of each users’ unique independent risk profile.
Our stellar team is composed of seasoned professionals and entrepreneurs with diverse and ample expertise in healthcare and other industries. We have more than 200 years of combined experience from leading companies such as Novartis, Pfizer, Abbott, Teva, and Johnson & Johnson.
Welwaze Medical is headquartered in Miami, Florida, a city that has nurtured many successful biomedical and medical device companies and world-class health systems and specialty care centers. Welwaze has received numerous awards and accolades, including the prestigious Novartis Innovation Week award, a nomination at the StartUp Health Moonshot Showcase, and a finalist award for the Lyfebulb Helsinn Innovation Summit for Oncology.
